{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:03:28Z","timestamp":1793754208753,"version":"4.6.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Adalimumab and secukinumab are commonly used for moderate to severe psoriasis vulgaris (PV). Although distinct individual responses to and impaired effectiveness of these biological agents occur occasionally, little is known about the underlying reasons. Here, we report a proteomic analysis of psoriatic lesions from patients treated with these drugs using data-independent acquisition mass spectrometry (DIA-MS). Thousands of differentially expressed proteins (DEPs) changed over 12 weeks of treatment. Network analysis showed that DEPs could interact and induce transformation in matrix components, metabolic regulation, and immune response. The results of parallel reaction monitoring (PRM) analysis suggested that S100s, STAT1, KRT2, TYMP, SOD2, HSP90AB1, TFRC, and COL5A1 were the most significantly changed proteins in both groups. There was a positive association between the Psoriasis Area and Severity Index (PASI) score and three proteins (TFRC, IMPDH2, KRT2). Our study findings suggest that inhibition of IL-17A and TNF-\u03b1 can induce changes in multiple molecules in psoriatic lesions and have an overlapping influence on the immune response and process through direct or indirect effects.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1015182","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T08:08:54Z","timestamp":1669104534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["IL-17A and TNF-\u03b1 inhibitors induce multiple molecular changes in psoriasis"],"prefix":"10.3389","volume":"13","author":[{"given":"Qiang","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi Bo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Xiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning Ning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.4029","article-title":"Comparison of biologics and oral treatments for plaque psoriasis: A meta-analysis","volume":"156","author":"Armstrong","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14712598.2019.1555235","article-title":"Anti-Il17 therapies for psoriasis","volume":"19","author":"Silfvast-Kaiser","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40257-017-0328-3","article-title":"Choosing first-line biologic treatment for moderate-to-Severe psoriasis: What does the evidence say","volume":"19","author":"Amin","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16102","article-title":"Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-Severe plaque psoriasis","volume":"178","author":"Egeberg","year":"2018","journal-title":"Br J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1688756","article-title":"Failure rates and survival times of systemic and biologic therapies in treating psoriasis: A retrospective study","volume":"32","author":"Sutaria","year":"2021","journal-title":"J Dermatol Treat"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1727439","article-title":"Clinical and histopathological characterization of eczematous eruptions occurring in course of anti il-17 treatment: A case series and review of the literature","volume":"20","author":"Caldarola","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20178126","article-title":"Data-independent acquisition-based swath-Ms for quantitative proteomics: A tutorial","volume":"14","author":"Ludwig","year":"2018","journal-title":"Mol Syst Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jid.2019.06.128","article-title":"Data independent acquisition proteomic analysis can discriminate between actinic keratosis, bowen's disease, and cutaneous squamous cell carcinoma","volume":"140","author":"Azimi","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.08.048","article-title":"Quantitative proteomics identifies reduced Nrf2 activity and mitochondrial dysfunction in atopic dermatitis","author":"Koch","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/thno.31144","article-title":"In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"B-defensin 2 is a responsive biomarker of il-17a-Driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.04.041","article-title":"A framework for multi-omic prediction of treatment response to biologic therapy for psoriasis","volume":"139","author":"Foulkes","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","article-title":"Multi-organ proteomic landscape of covid-19 autopsies","volume":"184","author":"Nie","year":"2021","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/gr.092759.109","article-title":"Circos: An information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinf (Oxford England)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-191","article-title":"Stem: A tool for the analysis of short time series gene expression data","volume":"7","author":"Ernst","year":"2006","journal-title":"BMC Bioinf"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9998-8","article-title":"Network and pathway-based analyses of genes associated with parkinson's disease","volume":"54","author":"Hu","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.04.029","article-title":"Il-17a inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis","volume":"144","author":"Krueger","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2009.10.036","article-title":"Correlation of mrna and protein in complex biological samples","volume":"583","author":"Maier","year":"2009","journal-title":"FEBS Lett"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0208-5","article-title":"Proteogenomic analysis of psoriasis reveals discordant and concordant changes in mrna and protein abundance","volume":"7","author":"Swindell","year":"2015","journal-title":"Genome Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.05.039","article-title":"A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways","volume":"158","author":"Taipale","year":"2014","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14302","article-title":"The Hsp90 inhibitor rgrn-305 exhibits strong immunomodulatory effects in human keratinocytes","volume":"30","author":"Hansen","year":"2021","journal-title":"Exp Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.20.13.4505-4512.2000","article-title":"Stat1 as a component of tumor necrosis factor alpha receptor 1-tradd signaling complex to inhibit nf-kappab activation","volume":"20","author":"Wang","year":"2000","journal-title":"Mol Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18807","article-title":"Psoriasin (S100a7) is increased in the serum of patients with moderate-to-Severe psoriasis","volume":"182","author":"Maurelli","year":"2020","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16032","article-title":"Stratum corneum levels of calprotectin proteins S100a8\/A9 correlate with disease activity in psoriasis patients","volume":"48","author":"Matsunaga","year":"2021","journal-title":"J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.05.064","article-title":"Modulation of Cd6 function through interaction with galectin-1 and -3","volume":"588","author":"Escoda-Ferran","year":"2014","journal-title":"FEBS Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.897","article-title":"Efficacy and safety of itolizumab, a novel anti-Cd6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-iii study","volume":"71","author":"Krupashankar","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08769.x","article-title":"Th17 cytokines interleukin (Il)-17 and il-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16004","article-title":"Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients","volume":"34","author":"Gerdes","year":"2020","journal-title":"J Eur Acad Dermatol Venereology JEADV"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-tnf therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21060","article-title":"Interleukin-17ra blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum","volume":"187","author":"Navrazhina","year":"2022","journal-title":"Br J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrd4534","article-title":"Unleashing the therapeutic potential of human kallikrein-related serine proteases","volume":"14","author":"Prassas","year":"2015","journal-title":"Nat Rev Drug Discovery"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jaci.2017.01.025","article-title":"Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of Par2 activity","volume":"140","author":"Zhu","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.intimp.2018.09.048","article-title":"Gallic Acid inhibits the expression of keratin 16 and keratin 17 through Nrf2 in psoriasis-like skin disease","volume":"65","author":"Zhang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020324","article-title":"Impact of adalimumab treatment on interleukin-17 and interleukin-17 receptor expression in skin and synovium of psoriatic arthritis patients with mild psoriasis","volume":"10","author":"Bolt","year":"2022","journal-title":"Biomedicines"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.11.024","article-title":"Tnf-A-Induced protein 3 (Tnfaip3)\/A20 acts as a master switch in tnf-A blockade-driven il-17a expression","volume":"142","author":"Urbano","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12710","article-title":"Evidence that a neutrophil-keratinocyte crosstalk is an early target of il-17a inhibition in psoriasis","volume":"24","author":"Reich","year":"2015","journal-title":"Exp Dermatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/art.38896","article-title":"Combined inhibition of tumor necrosis factor A and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: Development and characterization of a novel bispecific antibody","volume":"67","author":"Fischer","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key312","article-title":"Exposure-response analyses demonstrate no evidence of interleukin 17a contribution to efficacy of abt-122 in rheumatoid or psoriatic arthritis","volume":"58","author":"Khatri","year":"2019","journal-title":"Rheumatol (Oxford England)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201800650","article-title":"A review on quantitative multiplexed proteomics","volume":"20","author":"Pappireddi","year":"2019","journal-title":"Chembiochem Eur J Chem Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1015182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T08:08:57Z","timestamp":1669104537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1015182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2022.1015182"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1015182","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"article-number":"1015182"}}